Phase 1/2a study of MYO-101.

Next Previous
Trial Profile

Phase 1/2a study of MYO-101.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 20 Dec 2017

At a glance

  • Drugs MYO 101 (Primary)
  • Indications Sarcoglycanopathies
  • Focus Therapeutic Use

    • Most Recent Events

    • 20 Dec 2017 New trial record
    • 13 Dec 2017 Accrding to a Myonexus Therapeutics media release, this trial will initiate in early 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top